Healthcare
Live Price
Offline$24.23
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Biotest AG (BTTAY) is a Healthcare stock with a market cap of $943.03M. The stock last traded around $24.23. Baseline metrics include revenue growth of +6.1%, EPS growth of -77.8%, a dividend yield of 0.1%. What stands out right now is revenue +6.1%, EPS -77.8%, free cash flow +189.2% with operating margin 0.1% and ROIC 0.0%. The dividend is present but secondary, with a yield around 0.1%. Valuation sits in the middle of the pack at price/sales 4.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BTTAY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BTTAY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BTTAY Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BTTAY and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
0.12%
Trailing 12M Payout
$0.01
Last Payout
| Ex-Date | Record | Pay | Dividend | Adj | Frequency |
|---|---|---|---|---|---|
| Jul 7, 2025 | Jul 7, 2025 | Jul 22, 2025 | $0.01 | $0.01 | Irregular |
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.